Quratis Inc
348080
Company Profile
Business description
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.
Contact
306, 13, Teheran-ro 64-gil
Gangnam-gu
Seoul
KORT: +82 262047727
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
70
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,520.20 | 9.50 | 0.11% |
| CAC 40 | 7,823.79 | 50.04 | -0.64% |
| DAX 40 | 23,501.47 | 137.09 | -0.58% |
| Dow JONES (US) | 42,129.08 | 11.35 | -0.03% |
| FTSE 100 | 8,572.77 | 30.15 | -0.35% |
| HKSE | 23,640.65 | 532.38 | 2.30% |
| NASDAQ | 19,114.42 | 104.33 | 0.55% |
| Nikkei 225 | 38,128.13 | 55.13 | -0.14% |
| NZX 50 Index | 12,779.26 | 7.48 | -0.06% |
| S&P 500 | 5,892.10 | 5.55 | 0.09% |
| S&P/ASX 200 | 8,279.60 | 10.60 | 0.13% |
| SSE Composite Index | 3,403.95 | 29.08 | 0.86% |